Attorney General Bruce Beemer announced today that his office is joining nineteen other states in a federal antitrust suit against six pharmaceutical companies.
These companies are accused of conspiring to fix prices of generic drugs in order to reduce competition and increase the cost for consumers.
The suit was filed in the U.S. District Court for the District of Connecticut against Heritage Pharmaceuticals, Inc., Aurobindo Pharma USA, Inc., Citron Pharma, LLC, Mayne Pharma (USA), Inc., Mylan Pharmaceuticals, Inc. and Teva Pharmaceuticals USA, Inc.
“The conduct alleged in the lawsuit resulted in the Commonwealth and consumers throughout the nation paying substantially higher prices for many generic pharmaceutical drugs,” Attorney General Beemer said. “It is critical for our office to be a part of the effort to prevent similar activity that will undoubtedly have a negative impact on consumers.”
The lawsuit concerns two drugs, the antibiotic doxycycline hyclate delayed release as well as the oral diabetes medication glyburide.
Other states joining Pennsylvania in this suit include: Delaware, Florida, Hawaii, Idaho, Iowa, Kansas, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Minnesota, Nevada, New York, North Dakota, Ohio, Virginia and Washington.
Loading ...
2 Responses
And the GOP blames Obamacare for high medical costs.
I’m a physician who makes house and hotel calls, and I give out medication gratis. Patient like that, and it’s not a big sacrifice because most drugs for the common conditions I see are cheap. One of my mainstays is doxycycline, a very old antibiotic released in the 1960s but still the best treatment for many infections. Every few years, I buy a bottle of five hundred for about thirty dollars. When I was about to re-order last year my supplier’s catalogue quoted a price of $1650 for five hundred. I thought: that must be a typo. But it wasn’t.